Expression and Clinical Significance of BCL2 Interacting Protein 3 Like in Multiple Myeloma
Multiple myeloma (MM) is one of the main blood disorders threatening human health today. This study aimed to examine the expression of BCL-2/adenovirus E1B 19 kDa-interacting protein 3-like (BNIP3L) in patients with MM and explore its mechanisms in silico. Bone marrow samples (n = 36 from patients w...
Main Authors: | Ruolin Li, Gang Chen, Yiwu Dang, Rongquan He, Angui Liu, Jie Ma, Zhian Ling |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2021-06-01
|
Series: | Technology in Cancer Research & Treatment |
Online Access: | https://doi.org/10.1177/15330338211024551 |
Similar Items
-
BCL2 Family Inhibitors in the Biology and Treatment of Multiple Myeloma
by: Gupta VA, et al.
Published: (2021-03-01) -
BCL-B (BCL2L10) is overexpressed in patients suffering from multiple myeloma (MM) and drives an MM-like disease in transgenic mice
by: Fenouille, Nina
Published: (2017) -
Role and Regulation of Pro-survival BCL-2 Proteins in Multiple Myeloma
by: Anne Slomp, et al.
Published: (2018-11-01) -
Prediction and prognostic significance of BCAR3 expression in patients with multiple myeloma
by: Weilong Zhang, et al.
Published: (2018-12-01) -
Clinical significance of granule‐containing myeloma cells in patients with newly diagnosed multiple myeloma
by: Kazuhito Suzuki, et al.
Published: (2016-11-01)